BOARD OF DIRECTORS

The Cancer Research & Treatment Fund (CR&T) is led by a Board of Directors that is supported by our Medical Advisory Board.  Together, they represent a broad cross-section of specialties and disciplines, working together to rapidly deploy funding to the frontlines of research and ensuring CR&T maintains its reputation as a leading voice in cancer research.

 
Thomas M. Silver, President

Principal, Silver Dollar Ventures, LLC.

 

Richard T. Silver, MD, Vice President, Medical Director

New York-Presbyterian/Weill Cornell Medicine

 

Joseph N. Aimi

President, Kenneth Bieber, Inc.

 

David T. Boule, Treasurer

Retired Partner, Ernst & Young

 

Maria Brisbane, CFA

Managing Director, Merrill Lynch

 

Terry Hermanson

President, Mr. Christmas, Inc.

 

Michael C. Kempner

Managing General Partner, KS Capital Partners, LP

 

Kasia McCormick
 
Amanda Johns Perez
 
Jeffrey Puglisi, MD

Glenville Medical Concierge Care

 
Richard J. Rose

Sr. Managing Director, Shufro, Rose & Co., LLC (Retired)

 

Todd J. Shaw

Senior Vice President, Morgan Stanley

 

Bharat Shah, PhD

Past President, Noble Investment Group (Retired)

 
AJ Shiekman

Strategy/Business Development Manager, Pure Storage

 

Adam Silver

 

Tim Silver

Portfolio Manager, Empery Asset Management, LP

 

Anne Templeton
 

Counsel

Nelson A. Boxer

Partner, Petrillo Klein & Boxer LLP

 

Staff

Chad Feay, MA, CHES®

Director of Administration and Development

 

Mara Sanderson

Administrative Specialist